Advertisement

Neurochemical Journal

, Volume 13, Issue 2, pp 137–144 | Cite as

A Comparison of mRNA Expression of Dopamine Receptors, Tyrosine Hydroxylase, and Dopamine Transporter in the Mesolimbic System of Rats with Different Levels of Alcohol Consumption

  • P. K. AnokhinEmail author
  • E. V. Razumkina
  • I. Yu. Shamakina
Experimental Articles
  • 3 Downloads

Abstract

Despite numerous studies, there is still no clear idea on the fine mechanisms of dysfunction of the brain dopamine system during the formation of alcohol dependence. In this work, we studied the expression of genes that encode tyrosine hydroxylase (TH), a key enzyme of dopamine synthesis, dopamine transporter (DAT), dopamine receptors of the second subtype (DRD2) in the midbrain, and dopamine receptors of the first and second subtypes (DRD1 and DRD2) in the striatum of rats that consumed alcohol from the 60th to 120th days of life in the “free choice” paradigm. The most pronounced changes, a decrease in mRNA expression of DRD1 and DRD2 in the striatum, as well as DAT and TH in the midbrain, were observed in animals with a growing preference for alcohol compared to a group of rats that controlled consumption at a constantly low level. In animals with initially stable high levels of alcohol preference, a decrease in the relative expression level of DRD1 and DRD2 mRNA in the striatum was found, while there was no difference in the expression of DAT and TH mRNA in the midbrain. The expression level of DRD2 mRNA in the midbrain did not differ in all the studied groups. These data suggest that changes in the expression of mRNA of DRD1 and DRD2 in the striatum do not depend on the initial alcohol preference and are determined by the level of alcohol intoxication, while the decrease in the level of TH and DAT mRNA in the midbrain may be one of the mech-anisms of loss of control over consumption.

Keywords

alcohol dopamine midbrain striatum gene expression mRNA 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anokhina, I.P. and Shamakina, I.Yu., in Rukovodstvo po narkologii (Manual on Narcology), Ivanets, N.N., Anokhina, I.P., Vinnikova, M.A., Eds., Moscow: GEOTAR-Media, 2016, pp. 96–115.Google Scholar
  2. 2.
    Blum, K., Thanos, P.K., Oscar-Berman, M., Febo, M., Baron, D., Badgaiyan, R.D., Gardner, E., Demetrovics, Z., Fahlke, C., Haberstick, B.C., Dushaj, K., and Gold, M.S., Journal of Reward Deficiency Syndrome, 2015, vol. 1, no. 3, pp. 95–104.Google Scholar
  3. 3.
    Tye, K.M., Mirzabekov, J.J., Warden, M.R., Ferenczi, E.A., Tsai, H.C., Finkelstein, J., Kim, S.Y., Adhikari, A., Thompson, K.R., Andalman, A.S., Gunaydin, L.A., Witten, I.B., and Deisseroth, K., Nature, 2013, vol. 493, pp. 537–541.CrossRefGoogle Scholar
  4. 4.
    Lammel, S., Tye, K.M., and Warden, M.R., Genes, Brain and Behavior, 2014, vol. 13, pp. 38–51.CrossRefGoogle Scholar
  5. 5.
    Ikemoto, S., Yang, C., and Tan, A., Behavioural Brain Research, 2015, vol. 290, pp. 17–31.CrossRefGoogle Scholar
  6. 6.
    Ashok, A.H., Marques, T.R., Jauhar, S., Nour, M.M., Goodwin, G.M., Young, A.H., and Howeset, O.D., Molecular Psychiatry, 2017, vol. 22, no. 5, pp. 666–679.CrossRefGoogle Scholar
  7. 7.
    Belujon, P. and Grace, A.A., Int. J. Neuropsychopharmacol., 2017, vol. 20, no. 12, pp. 1036–1046.CrossRefGoogle Scholar
  8. 8.
    Blum, K., Thanos, P.K., Wang, G.J., Febo, M., Demetrovics, Z., Modestino, E.J., Braverman, E.R., Baron, D., Badgaiyan, R.D., and Gold, M.S., Curr. Pharm. Des, 2018, vol. 23, no. 39, pp. 6050–6061.CrossRefGoogle Scholar
  9. 9.
    Most, D., Ferguson, L., and Harris, R.A., Handbook of Clinical Neurology, 2014, vol. 125, pp. 89–111.CrossRefGoogle Scholar
  10. 10.
    Morganstern, I. and Tejani-Butt, S., Neurochemical Research, vol. 35, no. 11, pp. 1708–1715.Google Scholar
  11. 11.
    Hirth, N., Meinhardt, M.W., Noori, H.R., Salgado, H., Torres-Ramirez, J., Uhrig, S., Broccoli, L., Vengeliene, V., Roßmanith, M., Perreau-Lenz, S., Kohr, G., Sommer, W.H., Spanagel, R., and Hansson, A.C., Proc. Natl. Acad. Sci. U. S. A., 2016, vol. 113, no. 11, pp. 3024–3029.CrossRefGoogle Scholar
  12. 12.
    Koob, G.F. and Volkow, N.D., Neuropsychopharmacology, 2010, vol. 35, no. 1, pp. 217–238.CrossRefGoogle Scholar
  13. 13.
    Diana, M., Front. Psychiatry, 2011, vol. 2, p. 64.CrossRefGoogle Scholar
  14. 14.
    Tupala, E. and Tiihonen, J., Brain Res., 2005, vol. 1031, no. 1, pp. 20–29.CrossRefGoogle Scholar
  15. 15.
    Bice, P.J., Liang, T., Zhang, L., Strother, W.N., and Carr, L.G., Mamm. Genome, 2008, vol. 19, pp. 69–76.CrossRefGoogle Scholar
  16. 16.
    Spiga, S., Talani, G., Mulas, G., Licheri, V., Fois, G.R., Muggironi, G., Masala, N., Cannizzaro, C., Biggio, G., Sanna, E., and Diana, M., Proc. Natl. Acad. Sci. U. S. A., 2014, vol. 111, no. 35, pp. E3745–E3754.CrossRefGoogle Scholar
  17. 17.
    Tiihonen, J., Vilkman, H., Räsänen, P., Ryynänen, O.P., Hakko, H., Bergman, J., Hämäläinen, T., Laakso, A., Haaparanta-Solin, M., Solin, O., Kuoppamäki, M., Syvälahti, E., and Hietala, J., Mol. Psychiatry, 1998, vol. 3, no. 2, pp. 156–161.CrossRefGoogle Scholar
  18. 18.
    Kawahata, I., Evelyn, G.R., Huinan, X., Ohtaku, S., Tomioka, Y., and Yamakuni, T., Neuro. Endocrinol. Lett., 2017, vol. 38, no. 1, pp. 43–49.Google Scholar
  19. 19.
    Rothblat, D.S., Rubin, E., and Schneider, J.S., Neurosci. Let., 2001, vol. 300, no. 2, pp. 63–66.CrossRefGoogle Scholar
  20. 20.
    Siciliano, C.A., Locke, J.L., Mathews, T.A., Lopez, M.F., Becker, H.C., and Jones, S.R., Alcohol, 2017, vol. 58, pp. 25–32.CrossRefGoogle Scholar
  21. 21.
    Carroll, M.R., Rodd, Z.A., Murphy, J.M., and Simon, J.R., Alcohol, 2006, vol. 40, no. 2, pp. 103–109.CrossRefGoogle Scholar
  22. 22.
    Jiao, X., Paré, W.P., and Tejani-Butt, S.M., Brain Res., 2006, vol. 1073–1074, pp. 175–182.CrossRefGoogle Scholar
  23. 23.
    Weiss, F., Parsons, L.H., Schulteis, G., Hyytia, P., Lorang, M.T., Bloom, F.E., and Koob, G.F., J. Neurosci., 1996, vol. 16, no. 10, pp. 3474–3485.CrossRefGoogle Scholar
  24. 24.
    Cooper, J., Bloom, F., and Roth, R., The Biochemical Basis of Neuropharmacology, Oxford, UK: Oxford Univ. Press, 2003, p. 8.Google Scholar
  25. 25.
    Dumartin, B., Jaber, M., Gonon, F., Caron, M.G., Giros, B., and Bloch, B., Proc. Natl. Acad. Sci. USA, 2000, vol. 97, no. 4, pp. 1879–1884.CrossRefGoogle Scholar
  26. 26.
    Vengeliene, V., Bespalov, A., Roßmanith, M., Horschitz, S., Berger, S., Relo, A.L., Noori, H.R., Schneider, P., Enkel, T., Bartsch, D., Schneider, M., Behl, B., Hansson, A.C., Schloss, P., and Spanagel, R., Disease Models & Mechanisms, 2017, vol. 10, no. 4, pp. 451–461.CrossRefGoogle Scholar
  27. 27.
    Tapocik, J.D., Solomon, M., Flanigan, M., Meinhardt, M., Barbier, E., Schank, J.R., Schwandt, M., Sommer, W.H., and Heilig, M., The Pharmacogenomics Journal, 2013, vol. 13, no. 3, pp. 286–296.CrossRefGoogle Scholar
  28. 28.
    Heilig, M., Barbier, E., Johnstone, A.L., Tapocik, J., Meinhardt, M.W., Pfarr, S., Wahlestedt, C., and Sommer, W.H., Genes, Brain, and Behavior, 2017, vol. 16, no. 1, pp. 86–100.CrossRefGoogle Scholar
  29. 29.
    Sommer, W.H., Rimondini, R., Hansson, A.C., Hips-kind, P.A., Gehlert, D.R., Barr, C.S., and Heilig, M.A., Biol. Psychiatry, 2008, vol. 63, no. 2, pp. 139–145.CrossRefGoogle Scholar
  30. 30.
    Feltman, K., Borroto-Escuela, D.O., Ruegg, J., Pinton, L., de Oliveira, SergioT., Narvaez, M., Jimenez-Beristain, A., Ekstr, T.J., Fuxe, K., and Steensland, P., Alcoholism: Clinical and Experimental Research, vol. 42, no. 2, pp. 338–351.Google Scholar
  31. 31.
    Chen, X., Xu, L., Radcliffe, P., Sun, B., and Tank, A.W., Molecular Pharmacology, 2008, vol. 73, no. 6, pp. 1816–1828.CrossRefGoogle Scholar
  32. 32.
    Galleguillos, D., Fuentealba, J.A., Gomez, L.M., Saver, M., Gomez, A., Nash, K., Burger, C., Gysling, K., and Andreas, M.A.J., J. Neurochem., 2010, vol. 114, pp. 1158–1167.Google Scholar
  33. 33.
    Zhang, Y., Zhu, X., Bai, M., Zhang, L., Xue, L., and Yi, J., PLoS One, 2013, vol. 8, no. 7, p. e69934.CrossRefGoogle Scholar
  34. 34.
    Olszewski, P.K., Grace, M.K., and Fard, S.S., Le Greves, M., Klockars, A., Massi, M., Schioth, H.B., and Levine, A.S, Am. J. Physiol. Regul. Integr. Comp. Physiol., 2010, vol. 299, pp. R655–R663.CrossRefGoogle Scholar
  35. 35.
    Livak, K.J. and Schmittgen, T.D., Methods, 2001, vol. 25, no. 4, pp. 402–408.CrossRefGoogle Scholar
  36. 36.
    Green, A.S. and Grahame, N.J., Alcohol (Fayetteville, NY), 2008. vol. 42, no. 1, pp. 1–11.CrossRefGoogle Scholar
  37. 37.
    Bjorklund, A. and Dunnett, S.B., Trends Neurosci., 2007, vol. 30, no. 5, pp. 194–202.CrossRefGoogle Scholar
  38. 38.
    Smith, Y. and Villalba, R., Mov. Disord., 2008, no. Suppl. 3, pp. 534–547.Google Scholar
  39. 39.
    Scott, S.S., Gervasi, N.M., and Kaplan, B.B., Trends Cell. Mol. Biol, 2015, vol. 10, pp. 1–36.Google Scholar
  40. 40.
    Holt, C.E. and Schuman, E.M., Neuron, 2013, vol. 80, no. 3, pp. 648–657.CrossRefGoogle Scholar
  41. 41.
    Crispino, M., Chun, J.T., Cefaliello, C., Perrone, Capano C., and Giuditta, A., Dev. Neurobiol, 2014, vol. 74, no. 3, pp. 279–291.CrossRefGoogle Scholar
  42. 42.
    Melia, K.R., Trembleau, A., Oddi, R., Sanna, P.P., and Bloom, F.E., Exp. Neurol., 1994, vol. 130, no. 2, pp. 394–406.CrossRefGoogle Scholar
  43. 43.
    Gervasi, N.M., Scott, S.S., Aschrafi, A., Gale, J., Vohra, S.N., MacGibeny, M. A., Kar, A.N., Gioio, A.E., and Kaplan, B.B, RNA, 2016, vol. 22, no. 6, pp. 883–895.CrossRefGoogle Scholar
  44. 44.
    Nutt, D.J., Lingford-Hughes, A., Erritzoe, D., and Stokes, P.R., Nat. Rev. Neurosci., 2015, vol. 16, no. 5, pp. 305–312.CrossRefGoogle Scholar
  45. 45.
    Volkow, N.D., Wang, G.J., Telang, F., Fowler, J.S., Logan, J., Jayne, M., Ma, Y., Pradhan, K., and Wong, C., J. Neurosci., 2007, vol. 27, no. 46, pp. 12700–12706.CrossRefGoogle Scholar
  46. 46.
    Beck, A., Schlagenhauf, F., Wüstenberg, T., Hein, J., Kienast, T., Kahnt, T., Schmack, K., Hägele, C., Knutson, B., Heinz, A., and Wrase, J., Biol. Psychiatry, 2009, vol. 66, no. 8, pp. 734–742.CrossRefGoogle Scholar
  47. 47.
    Beaulieu, J.-M. and Gainetdinov, R.R., Pharmacological Reviews, 2011, vol. 63, no. 1, pp. 182–217.CrossRefGoogle Scholar
  48. 48.
    Chefer, V.I., Backman, C.M., Gigante, E.D., and Shippenberg, T.S., Neuropsychopharmacology, 2013, vol. 38, no. 13, pp. 2623–2631.CrossRefGoogle Scholar
  49. 49.
    Lalanne, L., Ayranci, G., Kieffer, B.L., and Lutz, P.-E., Frontiers in Psychiatry, 2014, vol. 5, p. 170.CrossRefGoogle Scholar
  50. 50.
    Shagiakhmetov, F.Sh., Proskuryakova, T.V., and Shamakina, I.Yu., Neirokhimiya, 2015, vol. 32, no. 4, p. 285–294.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2019

Authors and Affiliations

  • P. K. Anokhin
    • 1
    Email author
  • E. V. Razumkina
    • 1
  • I. Yu. Shamakina
    • 1
  1. 1.National Research Center of Narcology, Serbsky National Medical Research Center of Psychiatry and NarcologyMinistry of HealthMoscowRussia

Personalised recommendations